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Purpose: This report identifies the incidence of recurrent carotid stenosis after carotid 
endarterectomy (CEA) and records the na~ral history of the disease process to gain further 
insight into its proper management. 
Methods: A prospective surveillance protocol with duplex imaging and velocity spectral 
analysis was used to detect recurrent stenosis (> 50% diameter reduction) and to document 
the clinical outcomes of patients who underwent CEA. Between 1984 and 1993, 619 
consecutive CEAs were performed in 587 patients. 
Results: Recurrent carotid stenosis developed in 48 CEA sites (7.8%) during a mean 
follow-up interval of 34 months (range, 2 to 118 months). Normal results on intraop- 
erative assessment correlated with a 5.6% incidence of recurrent stenosis, compared with 
a 19% incidence when a residual hemodynamic abnormality was present (p < 0.0003). In 
the first year after surgery, there were no transient ischemic attacks, strokes, or carotid 
occlusions from recurrent stenosis, compared with a 27% morbidity rate in later follow-up 
(p < 0.01). Three patients with recurrent stenosis ubsequently had occlusion at the CEA 
site, two of whom had severe ipsilateral strokes. 
Conclusions: The incidence of recurrent carotid stenosis is low. Patients are at significant 
risk for neurologic morbidity when a recurrent stenosis occludes. With a 0.3% incidence of 
late stroke resulting from carotid bifurcation disease, these data confirm that CEA does 
provide long-term protection from stroke. (J Vase Surg 1996;23:749-54.) 
The incidence of stroke resulting from carotid 
endarterectomy (CEA) has been extensively studied. 
In the recent randomized trials that supported the 
clinical role of CEA in preventing stroke, it has been 
clearly shown that CEA can be performed safely and 
with an acceptably low incidence of perioperative 
stroke and death.l'2As the application of CEA broad- 
ens to include both symptomatic and asymptomatic 
patients with a critical stenosis, the data on recurrent 
stenosis and its effect on long-term neurologic mor- 
bidity and death becomes increasingly important. The 
incidence of recurrent stenosis reported in the litera- 
ture varies from 4% to 16%. 3-6 Previous studies have 
concluded that the natural history of recurrent carotid 
stenosis is benign. 7-1° Contradictory data, however, 
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indicate that half of  late ipsilateral strokes after CEA 
may be related to recurrent stenosis. 1~ No true 
consensus exists regarding the natural history of these 
lesions, and their treatment remains controversial. 
The purpose of this study, the use of a prospective 
carotid surveillance protocol, is to define the inci- 
dence of recurrent stenosis and record the natural 
history of the disease to gain further insight into the 
proper management of recurrent carotid stenosis. 
PAT IENTS AND METHODS 
Between January 1984 and June 1993, 619 con- 
secutive primary CEAs were performed on 587 pa- 
tients by the Vascular Surgery Service of the Medical 
College of Wisconsin at John L. Doyne Hospital and 
the Zablocki Veterans Affairs Medical Center. All 
patients were enrolled in a prospective carotid surveil- 
lance protocol with duplex imaging and velocity 
spectral analysis at 6 weeks, 3 months, 6 months, and 
then yearly intervals. The results of this carotid 
surveillance protocol were used to determine the 
incidence of recurrent stenosis, defined as a residual or 
recurrent lesion in the operated internal carotid artery 
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of>50% diameter reduction. The patients with recur- 
rent stenosis were then stratified into two groups: 
early recurrent stenosis (diagnosis made < 12 months 
after surgery) and late recurrent stenosis (diagnosis 
made > 12 months after surgery). The management of 
these patients was documented, and clinical outcomes 
were followed by clinical evaluation and by telephone 
interviews. The mean follow-up period was 34 
months (range, 2 to 118 months). 
The study group consisted of 526 CEAs in men 
and 93 in women; the patients' mean age was 65 years. 
The incidence of active tobacco use was 57%; hyper- 
tension, 72%; hyperlipidemia, 29%; cardiac disease, 
59%; and insulin-dependent diabetes, 10%. The indi- 
cations for carotid reconstruction were transient 
ischemic attacks (TIAs), amaurosis fugax, or both in 
334 patients (54%); stroke in 149 (24%); and an 
asymptomatic stenosis in 136 (22%). 
All procedures were performed with the patient 
under general anesthesia. An intraluminal shunt, at 
the discretion of the surgeon, was used in 88% of cases 
to maintain flow in the ipsilateral internal carotid 
artery. CEA was performed with standard vascular 
surgical techniques, including heparin anticoagula- 
tion and optical magnification. The arteriotomy was 
closed with a patch in 365 patients (59%), and closed 
primarily in 254 (41%). The patch was constructed 
with internal jugular vein in 198 (32%), saphenous 
vein in 142 (23%), and a prosthetic patch was used in 
25 (4%). Low-molecular weight dextran was given 
during surgery and continued for 24 hours after 
surgery. Aspirin was prescribed after surgery. 
All patients were monitored in an intensive care 
unit for 24 hours. Duplex imaging of the CEA site was 
performed uring surgery after completion of the re- 
construction and at 6 weeks, 3 months, 6months, and 
yearly intervals afterward. Recurrent stenosis was de- 
fined as a lesion of the internal carotid artery of > 50% 
diameter eduction. The accuracy of our vascular 
laboratory in identifying >50% stenosis of the internal 
carotid artery is 93%. 12 The patients were observed 
clinically for any neurologic event. The major clinical 
endpoint was stroke resulting from recurrent carotid 
bifurcation disease. When a neurologic deficit was en- 
countered, computed tomography, echocardio- 
graphy, duplex imaging, and arteriography were used 
to define the cause of the event. A stroke was attrib- 
uted to carotid bifurcation disease if the stenosis had 
progressed to >75% stenosis or occluded at the time a 
computed tomographic scan identified an ipsilateral 
hemispheric cerebrovascular accident. 
RESULTS 
The incidence of neurologic defect occurring in 
the perioperative period (30 days) was 1.9% (12 
patients). The mortality rate was 1.0% (6 patients); 
four patients died from fatal stroke and two from 
myocardial infarction. 
During the follow-up period recurrent stenosis 
developed in 48 CEA sites (7.8%). In this series 532 
CEA sites (86%) were assessed with intraoperative 
duplex or spectral analysis. Patients with normal 
results on intraoperative assessment had a 5.6% inci- 
dence of recurrent stenosis (26 of 464), compared 
with a 19% incidence of recurrent stenosis in patients 
with residual hemodynamic abnormalities at the 
time of intraoperative assessment (12 of 62; Z 2, 
p < 0.0003). This finding is consistent with previous 
data reported from our institution. 13No correlation 
was found between a residual hemodynamic abnor- 
mality and the incidence of perioperative stroke, 
carotid occlusion, or late stroke. The type of arteri- 
otomy closure did not affect he incidence of recur- 
rent stenosis. 
Early recurrent stenosis (diagnosis made <12 
months after surgery) developed at 22 CEA sites 
(3.6%), of which six (27%) represented the progres- 
sion of residual lesions detected with intraoperative 
duplex imaging and 16 developed e novo in patients 
with normal results on intraoperative studies. The 
recurrent stenosis was detected an average of 5.6 
months after surgery. Five lesions underwent repeat 
CEA. All of these lesions were asymptomatic and were 
operated on for progression to a critical stenosis, 
defined as >75% diameter reduction. The remaining 
17 patients were observed with serial duplex 
examinations; in this group no neurologic morbidity 
or carotid artery occlusions were present. 
Late recurrent stenosis (diagnosis made >12 
months after surgery) occurred at 26 CEA sites 
(4.2%). In three patients, recurrent disease, measured 
at 50% to 75% diameter reduction, was identified at 
24, 40, and 48 months after surgery: these CEA sites 
were found to be occluded at 43, 60, and 51 months, 
respectively. Two of these patients had a severe 
ipsilateral stroke. Four other patients in this group had 
TIAs and had repeat CEA. Nineteen patients with late 
recurrent stenosis had no neurologic sequelae. In the 
first year after surgery the incidence of TIA, stroke, or 
occlusion of the internal carotid artery from recurrent 
stenosis was 0%, compared with 27% for recurrent 
stenosis detected in later follow-up (Fisher's exact 
test, p < 0.01). 
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In follow-up beyond 30 days after CEA, eight 
patients had strokes, which were identified from 8 to 
51 months after surgery. Two strokes could be 
attributed to known recurrent carotid bifurcation 
disease, for an incidence of late stroke resulting from 
recurrent stenosis of 0.3% (2 of 619). Three patients 
had normal results on carotid arteriograms. One 
patient had an acute myocardial infarction and mul- 
tiple subsequent embolic events, including a cerebral 
infarction. In one case the stroke was caused by 
malignant hypertension and resulted in death; an- 
other had no lmown cause. Both patients, however, 
had a normal carotid lumen at autopsy. 
The mean follow-up period was 34 months 
(range, 2 to 18 months). Life table analysis of survival 
is presented (Table I and Fig. 1). 
D ISCUSSION 
The purpose of CEA is to prevent stroke by 
removing a source of emboli or a site of possible 
thrombosis. This operation came under close scrutiny 
in the past decade because ofperioperative stroke rates 
that approached 10% and the belief by some physi- 
cians that medical therapy posed less risk and was 
equally efficacious. 14 The data from the North Ameri- 
can Symptomatic Carotid Endarterectomy Trial and 
the Asymptomatic Carotid Atherosclerosis Study 
have supported the concept that in centers of surgical 
excellence CEA can be performed with an acceptably 
low rate of morbidity and mortality, thus providing 
superior protection from stroke when compared with 
best medical management.l,2 Now that CEA is being 
applied to a wider scope of patients, it is imperative 
that we examine the long-term results of surgery, 
including the incidence and natural history of recur- 
rent stenosis, and apply those data in our patient 
management. 
Recurrent carotid stenosis was first described in 
1976 by Stoney and Str ing TM however, controversy 
remains regarding its clinical significance and optimal 
management. We previously reported that residual 
hemodynamic abnormalities atthe CEA site lead to a 
higher incidence of recurrent stenosis. 13 This series 
supports those findings and the importance of techni- 
cal perfection in obtaining the best possible out- 
comes. 
Because many investigators believe that recurrent 
stenosis is a benign process, with only a minority of 
patients having neurologic symptoms, a conservative 
nonoperative strategy has prevailed. <8a6 In this study 
we looked at the natural history of recurrent stenosis 
and tried to identify a subgroup of recurrent lesions 
that may require a different management strategy. It 
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Fig. 1. Cumulative patient survival rates after 619 carotid 
bifurcation reconstruction between 1984 and 1993. 
has been suggested that an early recurrent stenosis is 
caused by a homogeneous fibrous plaque that results 
from myointimal hyperplasia, nd that recurrent le- 
sions, which develop later in the postoperative course, 
are caused by recurrent atherosclerosis. H Of  the 22 
patients in this series with early recurrent stenosis, five 
underwent repeat CEA because of progression of the 
stenosis to >75% diameter eduction; all of these 
lesions were asymptomatic. The remaining 17 pa- 
tients were treated without surgery. No TIAs, strokes, 
or carotid occlusions occurred in this group. 
Twenty-six patients had late recurrent stenosis. In 
this group no repeat CEAs were performed in asymp- 
tomatic patients. The group with late recurrent dis- 
ease had a significantly higher incidence ofneurologic 
events. Four patients had TIAs that lead to repeat 
CEA. Three patients had carotid occlusion, two of 
whom went on to have a stroke. The overall incidence 
of neurologic omplication or carotid occlusion in 
this group was 27% (7 of 26). A case could be made 
that the two groups are not comparable because five 
patients with early recurrent stenosis underwent re- 
peat CEA; thus we are unable to determine how many 
would have developed neurologic deficits. The same 
group of surgeons were managing the patients, how- 
ever, and the same indications for repeat CEA were 
used. For both groups the indications for reoperation 
were progression to critical stenosis or the occurrence 
symptoms. In patients with early restenosis, all of 
whom were asymptomatic, the indication was the de- 
gree of stenosis. In the late group, however, all pa- 
tients became symptomatic before the critical stenosis 
that prompted intervention was detected. It then can 
be extrapolated that the patients with early recurrent 
disease had lesions that may have progressed in diam- 
eter reduction but were less likely to cause symptoms. 
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Table I. Life-table analysis of cumulative patient survival after 619 carotid artery reconstructions 
performed from 1984 to 1993 
No. of patients No. of patients No. of Cumulative survival 
Interval (too) at risk withdrawn terminal events rate SE (%) 
0 619 60 12 1.0 - -  
6 547 53 9 .98 0.0058 
12 485 62 12 .96 0.0080 
18 411 52 6 .94 0.1060 
24 353 45 11 .92 0.1203 
30 297 39 5 .89 0.0148 
36 253 39 6 .88 0.0162 
42 208 28 3 .85 0.0182 
48 177 34 1 .84 0.0194 
54 142 23 5 .83 0.0200 
60 114 3 26 .80 0.0238 
66 85 21 0 .78 0.0268 
72 64 19 0 .78 0.0268 
Some studies have suggested that recurrent ca- 
rotid stenosis occurs in a heterogeneous population 
and that a different plaque formation results in 
different clinical consequences. Washburn et al.n 
demonstrated that early restenosis, presumably result- 
ing from myointimal hyperplasia, led to significantly 
fewer neurologic events than late restenosis, presum- 
ably resulting from atherosclerosis. Sterpetti et al. 17 
observed ifferent clinical outcomes among patients 
with recurrent lesions at different imes in the post- 
operative period. They studied ultrasonographic and 
pathologic data and demonstrated that homogeneous 
soft plaque, homogeneous hard plaque, and hetero- 
geneous plaque correlate with myointimal hyperpla- 
sia, fibrous atherosclerotic plaque, and complex ath- 
erosclerotic plaque, respectively. The homogeneous 
plaque occurred earlier in the postoperative course, 
and symptoms of cerebral ischemia were more com- 
mon at the later stage of heterogeneous plaque. 
Of the patients tudied in this report, eight had a 
stroke in the late postoperative period. Only two of 
these patients (0.3%) had a stroke attributable to 
carotid bifurcation disease. These data confirm the 
belief that CEA is a durable operation, and that the 
goal of CEA, stroke prevention, is being met after 
long-term analysis. 
Long-term follow-up is essential to conduct a 
meaningful outcome analysis for CEA. Table I, used 
to construct he survival life table, identifies the 
number of patients who were lost to follow-up. The 
vascular surgeon is challenged to maintain a pro- 
tracted relationship with patients after CEA. Because 
these patients have few residual symptoms or sequelae 
after the procedure, neither they nor their referring 
physician are inclined to maintain a degree of dedi- 
cated follow-up, compared, for example, with pa- 
tients treated for limb salvage, where a greater sense of 
dependency exists with the surgeon. Consequently, in 
this series there could have been more strokes that 
could be attributable tocarotid disease if the affected 
patients were lost to follow-up. This is an unavoidable 
dilemma. The conclusion regarding the durability of 
CEA, however, is clear. The incidence of late ipsilat- 
eral stroke resulting from recurrent carotid bifurca- 
tion disease is low. CEA is the gold standard in stroke 
prevention to which all other interventions must be 
compared before they are used in the clinical man- 
agement of carotid stenosis. 
The value of routine surveillance of carotid artery 
reconstructions may be questioned. Because the in- 
cidence of recurrent stenosis and subsequent s roke is 
low, a large number of patients must be observed to 
find the patient in whom recurrent stenosis develops 
that may progress to occlusion either with or without 
a stroke. Unfortunately, without comprehensive sur- 
veillance no cohort could be identified to be at risk 
other than those patients who had a residual stenosis 
from a less-than-perfect technical reconstruction of
the carotid bifurcation. The recurrent lesion, if al- 
lowed to progress to occlusion, has a poor outcome, 
with two of three patients in this study having strokes. 
Needless to say, considerable cost is incurred to 
identify this small number of patients. We recommend 
postoperative duplex examination at 6 weeks and 6 
months. I f  results are normal, we perform carotid 
duplex scans annually thereafter. 
CONCLUSION 
CEA can be performed safely and with an accept- 
able incidence of morbidity and death. Attention to 
technical perfection is essential in obtaining good 
perioperative and long-term results. Recurrent steno- 
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sis occurred at 7.8% of the CEA sites in our study, and 
early recurrent stenosis appeared to be more predict- 
ably benign compared with late recurrent stenosis, 
which had a higher incidence of  unheralded neuro- 
logic events. This operation is durable. With a rigor- 
ous follow-up protocol to identify and repair stenoses 
with >75% diameter eduction, late stroke can be 
minimized. 
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DISCUSSION 
Dr. Jeffrey R. Rubin (Youngstown, Ohio). I have 
several questions. First, do you currently correct the residual 
abnormalities? You found an increased number of recurrent 
lesions in patients who had residual abnormalities at the 
time of surgery. So obviously we need to decide whether or 
not these need to be corrected at the time of surgery. If you 
do not fix these, I would like to know why. The second 
question deals with the characteristics of the recurrent 
plaque. It is generally believed that lesions that occur within 
the first 12 months are different from the lesions that occur 
after the first 12 months. Did the authors actually notice a 
difference in the plaque characteristics of these two lesions? 
The third question has to do with the location of the 
recurrent lesion. Where was it located? Was it proximal, 
distal, or at the site of the CEA? The last question I have 
regards the duplex scanning and who performed the scans. 
Do you have your technical support staff come up to the 
operating room and perform the scans or do the surgeons 
perform the scans themselves? Who then performs the scans 
after surgery? 
Dr. Richard E. Carballo. Regarding your first ques- 
tion, residual abnormalities were found to be associated 
with a significant increase in recurrent s enosis fthe residual 
abnormality was > 50% by hemodynamic criteria or what we 
consider a D lesion, which would have a peak systolic 
velocity >125 and end diastolic velocity >100. If a lesion 
does, in fhct, have >50% diameter reduction, it is repaired. If
it is a 16%-to-49% lesion by our criteria, the arteriotomy is 
not repaired and the patient is observed. 
As far as the physical characteristics of the plaque, these 
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patients that we followed-up were not taken back to the 
operating room, and we never really got to examine the 
plaque itself. That is why we state in our conclusions that 
plaque in an early recurrent lesion is presumably a result of 
intimal hyperplasia. The location of the plaque is most 
commonly the carotid bifurcation. It does not appear that 
the carotid bifurcation isspared of disease and you have an 
isolated lesion at the distal end point. 
Regarding who performs the duplex scans, our vascular 
lab consists of several RVTs, who come into the operating 
room. The operating surgeon manually performs the du- 
plex imaging with the interpretation aided by the RVT. All 
follow-up is carried out by the RVTs in the vascular lab at the 
intervals presented in the paper. 
Dr. John L. Glover (Royal Oak, Mich.). Would you 
please elaborate on your indications for repair of late 
stenosis? I believe the stenoses you operated on were 
primarily symptomatic, but you have indicated that it 
should be repaired in certain instances. Would you elaborate 
on that? 
Dr. Carballo. Well, Dr. Glover, our indication for repair 
for both early and late recurrent stenosis at the rime of the 
study were the same. We basically followed the same 
therapeutic regimen for all patients: patients who developed 
a recurrent stenosis were observed until the lesion became 
symptomatic or until it progressed to a critical stenosis. 
What is interesting in the data is that observing these 
patients thc samc way, patients with early recurrent stenosis 
seem to have a more stable lesion in that they were able to 
be observed progressively without symptoms occurring. No 
patients in the early recurrent group were operated on for 
symptoms; whereas all of the patients in the late recurrent 
group were operated on for symptoms. That, in and of itself, 
I think, is some evidence that hc early recurrent lcsion is not 
quite as bad an actor as the late recurrent lesion. 
Dr. Steven M. Dosick (Toledo, Ohio). You had a very 
aggressive follow-up with your duplex scanning. There is 
controversy in our group in Toledo right now because we 
have an aggressive program for distal follow-up. What are 
you going to do with your duplex scanning now that you 
kiaow thc data as such? 
Dr. Carballo. Well, that's a good question. The duplex 
scanning that we have employed isquite rigorous; part of it 
is done obviously for patient care, and also partially for 
academic interest in obscrving our carotid endarterecto- 
mics and seeing the natural history of these lesions. I think 
there is no question that having 3 months, 6 months, 9 
months, and yearly duplex examinations may be overdoing 
it. I think that is something that is going to be worked out 
on a broad scale, looking not only at our institution but 
looking at reimbursement, and also looking at what strokc 
rate, and what morbidity we are saving from doing this 
surveillance and if it will be worth it. That is something that 
still needs to be worked out. 
